Nancy

Pre-existing cell states predict resistance to multiple treatments dlvr.it/TRn0Zw

@AbdelWahablab @natgenet @KellyLBolton @WashU @IrenaeusChan @PuZhang09980432 Congratulations!

Excited to announce a paper out today in @natgenet.nature.com identifying an approach to mitigate the risk of therapy-related myeloid malignancies in patients with cancer. Collaboration with @KellyLBolton @WashU and led by @IrenaeusChan & @PuZhang09980432 nature.com/articles/s4158…

Now online! MYC binding to nascent RNA suppresses innate immune signaling by R-loop-derived RNA-DNA hybrids dlvr.it/TQWcrR

Congratulations to Nancy Arthur, our January #CGCVolunteerSspotlight! 👏 As a CGC trainee volunteer and Communications Committee member, Nancy plays a vital role in our community. Learn more about her here: buff.ly/B0VIrFG #CGCVolunteers #genomics #cancer #research

@DrArunCMC Fun times!

Still remains one of the prettiest/weirdest 😅 karyotype I have seen, thanks to @NancyArthurPhD. Perfect example of flow cytometry, cytogenetics and molecular diagnostics blending together to diagnose a rare entity. More at rdcu.be/cY0bX

@as_klepian Christmas in @cmcvelloreoff was really special.

2025 Update on MRD in Acute Myeloid Leukemia: A Consensus Document from the ELN-DAVID MRD Working Party ashpublications.org/blood/article/…

@Dr_AmerZeidan @ASH_hematology 2014 San Francisco.

Concluding another amazing #ASH2025 @ASH_hematology meeting. The picture is me attending my first ASH meeting with my first poster in San Francisco in 2008 and I have been to every single ASH meeting since then. When was your first ASH?

🚨 This is it people … you heard it first at #ASH25 🚨 ELN #MRD 205 guidelines are in press in @BloodPortfolio Bad news: It’s more complicated than before… 🤯 Good news: there’s an app for it 😉 eln-aml-mrd-2025.vercel.app

The scariest thing in academia 😅

New preprint! We know cancer cells with somatic mutations are selected to evade the immune system. With @imartincorena Peter Campbell @ZJL1435957 @QuotientTx, we asked if immune cells with somatic mutations are also selected to fight cancer. biorxiv.org/content/10.110… 1/5

Rapid epigenomic classification of acute leukemia | Nature Genetics nature.com/articles/s4158…

"We added the requested experiments and thank the reviewers for their helpful suggestions"

Congratulations @OffCMCVellore on retaining #NIRF ranking as 3rd best Medical College in India. @dpradhanbjp Benchmarks help but staying true to the call to "Not to be ministered unto, but to minister" will define who we really are meant to be. Three cheers to the Silver & Blue

We mourn the loss of Dr. Stuart Kornfeld - an incredible teacher & mentor. He was an outstanding role model & leader, fostering research training, mentorship & scientific success for generations of trainees. Dr. Kornfeld was known for providing lifelong support to his trainees.

A generative artificial-intelligence tool has designed a synthetic CRISPR system that successfully edits human DNA go.nature.com/3JadkRy

🌍 Thrilled to announce our International Speaker Lineup for the 5th HCC Annual Meeting! 🩸 Join us Oct 3–5, 2025 at NCI-AIIMS, Jhajjar — where real-world expertise meets meaningful progress in blood cancer care. 🔗 More: hemecancer.org/5th-annual-mee… #HCCIndia #Hematology2025

New in @NatureBiotech: a team led by scientists at MSK and @UofT have developed a new platform to facilitate the study of RNA-binding proteins (RBPs) across hundreds of species of plants, insects, and animals. Learn more: go.nature.com/4l3LYtI nature.com/articles/s4158…

The Cancer Genomics Consortium is thrilled to announce the publication of a landmark consensus guideline honed by the CGC’s Plasma Cell Neoplasm Working Group in Blood Cancer Journal. Learn more here: buff.ly/89CuBtz #CGCVolunteers #genomics #cancer #research #genetics

@WashUHematology @WashUDeptMed @mpndoc @ALYoung85 Congratulations!

Congratulations to Drs. Oh and Young on their well deserved faculty promotions! 🥳@washudeptmed hematology.wustl.edu/congratulation…